Published in Vaccine Weekly, October 27th, 2004
Gaithersburg, Maryland-based MedImmune had planned to make 1 million to 2 million doses for this flu season after selling less than 500,000 in the product's disappointing first season.
However, that was before the British government announced that it had shut down a major flu-shot supplier, citing manufacturing problems at the Chiron Corp. factory in England where roughly 46 million doses destined for the United States had been made. The move left the United States facing the loss...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly